Navigation Links
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
Date:6/28/2009

RICHMOND, Calif., June 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that a key research milestone has been achieved in its Research and License Agreement with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein production purposes using Sangamo's proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. Genentech scientists demonstrated the successful knockout of two preselected genes in a Chinese hamster ovary (CHO) cell line. The milestone achievement triggered a payment from Genentech to Sangamo.

"Achievement of this milestone demonstrates the progress under our agreement with Genentech," said Edward Lanphier, Sangamo's president and chief executive officer. "Our ZFN technology is currently being used by major players in pharmaceutical protein production to streamline the process of cell line production, increase the yield and improve the characteristics of biologic drugs, such as antibodies, that are manufactured in mammalian cells."

"Our ZFNs provide the gold standard technology for specifically editing target genes in mammalian cells," stated Philip Gregory, D. Phil., Sangamo's vice president of research. "Moreover, the efficiency of this approach obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ability to quickly and selectively knock out multiple genes in the same cell line creates endless possibilities for biopharmaceutical companies to improve their manufacturing capability."

About Sangamo

Sangamo BioSciences, Inc. is focused on researching and developing zinc finger DNA-binding protein (ZFP) technology for therapeutic gene regulation and mo
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
2. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
3. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
8. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
9. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
10. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
11. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... , June 17, 2013  A little known drug ... under scrutiny by the U.S. Supreme Court – and a ... issue could not have come at a better time for ... result from the Rx industry tactic are all too apparent ... of 50+ New Yorkers, state residents are in a near ...
(Date:6/17/2013)... PHILADELPHIA , June 17, 2013 ... support; program promoted through new ,Wake-Up Call, campaign ... Elsevier , a world-leading provider of scientific, technical ... the launch of EduCode ® Doc ... physicians and other practitioners. EduCode Doc Briefs is ...
(Date:6/17/2013)... , June 14, 2013 The law firm ... commenced what is believed to be the first suit in ... pancreatic cancer in the user of two common anti-diabetic drugs, ... Staten Island resident Robert Cataletto ... Pharmaceuticals, LLC, et al., E.D.N.Y. CV 13-3411. Mr. ...
Breaking Medicine Technology:Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 3Elsevier Launches EduCode Doc Briefs to Help Physicians Implement ICD-10 2Elsevier Launches EduCode Doc Briefs to Help Physicians Implement ICD-10 3Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2
(Date:6/17/2013)... (PRWEB) June 17, 2013 "Do you think ... are texting, emailing or using your phone even with a ... warns it is just as dangerous as not using a ... those of you using Facebook, texting, emailing etc." ... and alters their reflexes that distract the brain, according to ...
(Date:6/17/2013)... New York, NY (PRWEB) June 17, 2013 ... Block O'Toole & Murphy, LLP are pleased to ... http://www.blockotoole.com/Attorneys/Stephen-J-Murphy.shtml ) and David L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ... radio station Z100 (100.3 FM) this Sunday, June ... Mr. Scher will be guests on Kevin Burke's ...
(Date:6/17/2013)... According to a June 11, 2013 ABC News article, titled ... surfaces about the negative effects of sun on the ... skin care routine, as the sun's rays can ... “I agree with the article's suggestions for the best way ... Epione Beverly Hills. “Apply a minimum of SPF 30, twenty ...
(Date:6/17/2013)... As da Vinci robot lawsuit ... Bernstein Liebhard LLP notes that a recent report aired ... the disturbing robotic surgery complications alleged to have been caused ... the June 14th broadcast revealed that the U.S. Food & ... da Vinci patients who suffered burns, cuts and infections since ...
(Date:6/17/2013)... 17, 2013 San Antonio Eye Center PA has ... St. has just opened up a new portion of the office, ... downtown optical shop over the years, and SA Eye Center has ... Center one step closer to providing patients with everything they need ... The downtown optical shop is the largest SA Eye Center in ...
Breaking Medicine News(10 mins):Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Skin Care – Answers to Your Sunscreen Questions 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3Health News:San Antonio Eye Center PA Opens New Optical Shop 2
... Haiti , Jan. 19 One week later, ... of delivering aid in the aftermath of the Haiti ... aid is beginning to get through, the impact of the ... combined with a destroyed office and warehouse and the loss ...
... , JACKSONVILLE, Fla. and DES ... Inc. ( www.USPreventiveMedicine.com ) will partner with the Iowa Chronic Care ... not yet eligible for Medicare reduce health risks and live longer, ... equal amounts by a grant/cooperative agreement from the Centers for Disease ...
... PHILADELPHIA , Jan. 19 Independence Blue ... been promoted to chief marketing executive. Taylor will report to ... Independence Blue Cross. , As chief marketing executive, Taylor ... Cross (IBC) and two of the company,s third-party administrators:  Independence ...
... , , PHILADELPHIA , Jan. ... Paul A. Tufano has assumed an expanded role of senior ... continue to report to IBC president and CEO Joseph A. ... counsel since November 1999 when he joined IBC. , ...
... , ... Lindt Chocolate , the world,s leading producer of premium chocolate, announces it ... Autism program. For the second year, Lindt will honor ordinary individuals ... home or community.  The Lindt Unsung Heroes of Autism program is part ...
... Providence, RI New research at Rhode Island Hospital has ... brain tumors which, once diagnosed, offer a poor prognosis and ... naturally-occurring hormone combined with chemotherapy, researchers were able to inhibit ... study and their findings are published in the Journal ...
Cached Medicine News:Health News:Haiti Earthquake: One Week Later, Aid Agencies Facing Challenges 2Health News:Iowa Farm Bureau Introduces Bold Initiative to Improve Health Care for Rural Iowans 2Health News:Iowa Farm Bureau Introduces Bold Initiative to Improve Health Care for Rural Iowans 3Health News:Iowa Farm Bureau Introduces Bold Initiative to Improve Health Care for Rural Iowans 4Health News:Taylor Promoted to Independence Blue Cross Chief Marketing Executive 2Health News:Taylor Promoted to Independence Blue Cross Chief Marketing Executive 3Health News:Independence Blue Cross Announces New, Expanded Role For Key Executive 2Health News:Independence Blue Cross Announces New, Expanded Role For Key Executive 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 2Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 4Health News:Researchers find a treatment for deadly brain tumor 2
It provides cranial support in either supine or semi-sitting procedures....
Hudson cranial drill set which includes burr (9 mm), burr (14 mm), burr (16 mm), burr (22 mm), cerebellar extension, brace and sterilizing case....
Children's hospital hand drill, hexagonal handle, twist drill diameter 4.2 mm....
Hudson hand drill with extension piece....
Medicine Products: